Hair Loss

The clinician begins by distinguishing temporary shedding from progressive pattern thinning, because management differs substantially. Attention is given to common triggers such as stress, illness, caloric restriction, and micronutrient deficiencies that can worsen shedding. Family history and distribution patterns are discussed as clues that support androgenetic hair loss rather than inflammatory scalp disease. The presenter recommends reviewing medications and recent hormonal changes that may shift follicle cycling in susceptible individuals. Evaluation is framed around identifying reversible contributors while setting realistic expectations for regrowth timelines and variability. Patients are encouraged to document baseline photos, because consistent comparisons reduce anxiety and improve decision-making. Overall guidance emphasizes a structured plan that combines symptom context with appropriate clinical evaluation and follow-up.

Treatment options are reviewed, including topical therapies, prescription approaches, and supportive lifestyle strategies that protect follicle health. Finasteride and related therapies are discussed with emphasis on informed consent, side-effect risk, and gradual response expectations. Minoxidil is described as a commonly used option, with reminders about adherence and the possibility of initial shedding during adjustment. The clinician highlights that dosing decisions should be individualized, especially when patients have cardiovascular concerns or low blood pressure. Rather than stacking multiple medications immediately, the presenter recommends stepwise changes so response can be interpreted clearly. Nutrition, sleep, and scalp inflammation control are mentioned as practical levers that can improve overall outcomes alongside medication. Viewers are reminded that consistent routines and realistic timelines matter more than frequent protocol changes when assessing progress.

For patients on hormone therapy, the clinician discusses how androgen sensitivity and dihydrotestosterone exposure can influence hair outcomes. Instead of abrupt dose swings, careful adjustments and stable routines are recommended so symptoms can be interpreted with less noise. Follow-up planning includes deciding when to reassess, what success looks like, and when to pivot strategies if progress is limited. The presenter notes that dermatology referral can be appropriate for scarring patterns, significant inflammation, or unclear diagnosis. Monitoring is framed around safety, side effects, and patient goals, with documentation to support shared decision-making over time. Patients are encouraged to ask about warning signs that require prompt evaluation rather than waiting for progression. The discussion closes by emphasizing individualized evaluation, consistent routines, and thoughtful follow-up for safer, sustainable results.